Skip to main content
Clinical Trials/NCT04260074
NCT04260074
Completed
Not Applicable

Biomarkers in Head and Neck Cancer - Epigenetic Changes and Hypermethylation of Promoter-regions

Aalborg University Hospital1 site in 1 country40 target enrollmentMarch 11, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Head and Neck Cancer
Sponsor
Aalborg University Hospital
Enrollment
40
Locations
1
Primary Endpoint
Differences in epigenetic changes
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

With this study, the investigators will investigate the epigenetic changes, which may contribute to the development of head and neck squamous cell carcinomas.

Registry
clinicaltrials.gov
Start Date
March 11, 2020
End Date
July 14, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Christian Sander Danstrup

Associate Professor, M.D.

Aalborg University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • History of cancer
  • Uncontrolled comorbidity
  • Control group:
  • Inclusion Criteria :
  • Written informed consent
  • Normal buccal mucosal surface.
  • Normal ENT-examination
  • Exclusion Criteria:
  • History of cancer
  • Uncontrolled comorbidity

Outcomes

Primary Outcomes

Differences in epigenetic changes

Time Frame: 6 months

Differences between tumor- and healthy group

Study Sites (1)

Loading locations...

Similar Trials